Rapidly progressive glomerulonephritis caused by tegafur/gimeracil/oteracil resulted in diabetes nephropathy, in a patient with minor risk of diabetes nephropathy: a case report-Reference-Cited by-同舟云学术

Rapidly progressive glomerulonephritis caused by tegafur/gimeracil/oteracil resulted in diabetes nephropathy, in a patient with minor risk of diabetes nephropathy: a case report

Published:2020-05-07 Issue:4 Volume:9 Page:347-353
ISSN:2192-4449
Container-title:CEN Case Reports
language:en
Short-container-title:CEN Case Rep

Author:

Toriu Naoya^ORCID,Sawa Naoki,Imafuku Aya,Hasegawa Eiko,Sekine Akinari,Mizuno Hiroki,Yamanouchi Masayuki,Hiramatsu Rikako,Hayami Noriko,Hoshino Junichi,Kawada Masahiro,Suwabe Tatsuya,Ohashi Kenichi,Fujii Takeshi,Ubara Yoshifumi

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s13730-020-00485-7.pdf

Reference17 articles.

1. Lusco MA, Fogo AB, Najafian B, et al. AJKD atlas of renal pathology: thrombotic microangiopathy. Am J Kidney Dis. 2016;68:e33–e34.

2. George JN, Nester CM. Syndromes of thrombotic microangiopathy. New England J Med. 2014;371:654–66.

3. Toriu N, Sekine A, Mizuno H, et al. Renal-limited thrombotic microangiopathy due to bevacizumab therapy for metastatic colorectal cancer: a case report. Case Rep Oncol. 2019;12:391–400.

4. Frangié C, Lefaucheur C, Medioni J, et al. Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma. Lancet Oncol. 2007;8:177–8.

5. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. New England J Med. 2008;358:1129–36.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Cancer Treatment in Patients with Renal Dysfunction: The Role of Chemotherapy;Anti-Cancer Agents in Medicinal Chemistry;2023-10

2. A Case of Rapidly Progressive Diabetic Nephropathy Induced by Osimertinib;Case Reports in Nephrology and Dialysis;2023-08-08

3. XCL1 Aggravates Diabetic Nephropathy-Mediated Renal Glomerular Endothelial Cell Apoptosis and Inflammatory Response via Regulating p53/Nuclear Factor-Kappa B Pathway;Nephron;2021-09-09

4. Multiple drugs;Reactions Weekly;2021-05